title: [Premature rupture of membranes: pathophysiology of neurological impact].
abstract: The premature rupture of membranes (PROM) is responsible for 30 % of the premature births because of a high risk of associated chorioamnionitis. PROM and the perinatal infection are recognized as 2 of the main risk factors of periventricular leukomalacia and white matter disease in very preterm neonates. Inflammation associated with PROM is likely to induce neuronal or glial cell death at a developmental stage of great vulnerability for the developing brain. Several mechanisms (release of cytokines, accumulation of free radicals, excitotoxicity, apoptosis...) account for this deleterious effect. The decision to actively extract a fetus subjected to a fetal inflammatory response syndrome should take account of the risks of a proved intrauterine infection for both the mother and the fetus and the risks for the neonate related to a very preterm birth per se. A reasonable attitude seems not to maintain a fetus in an undoubtful septic context in utero if a preterm birth in the very short term appears unevitable. Practically, no consensus gives a recommendation between aggressive or conservative management in case of PROM within 30 and 34 weeks'gestation. Expectant management seems to be indicated before 28 weeks'gestation and intentional delivery could be recommended beyond 34 weeks'gestation due to increased maternal risks compared to relatively low incidence of the complications of prematurity at this term.
authors.affiliation: Service de réanimation et de pédiatrie néonatales, hôpital Robert-Debré, 48 bd Sérurier 75019 Paris. olivier.baud@rdb.aphp.fr
authors.forename: O
authors.initials: O
authors.lastname: Baud
authors.forename: R H
authors.initials: RH
authors.lastname: Fontaine
authors.forename: P
authors.initials: P
authors.lastname: Olivier
authors.forename: L
authors.initials: L
authors.lastname: Maury
authors.forename: F
authors.initials: F
authors.lastname: El Moussawi
authors.forename: I
authors.initials: I
authors.lastname: Bauvin
authors.forename: M
authors.initials: M
authors.lastname: Arsac
authors.forename: S
authors.initials: S
authors.lastname: Hovhannisyan
authors.forename: C
authors.initials: C
authors.lastname: Farnoux
authors.forename: Y
authors.initials: Y
authors.lastname: Aujard
mesh_terms: D000818:Animals; D001812:Blood-Brain Barrier; D002547:Cerebral Palsy / Q000209:etiology*; D002821:Chorioamnionitis / Q000209:etiology; D004195:Disease Models, Animal; D005260:Female; D005315:Fetal Diseases / Q000209:etiology; D005322:Premature Rupture of Fetal Membranes / Q000503:physiopathology* / Q000628:therapy; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000209:etiology*; D007969:Leukomalacia, Periventricular / Q000209:etiology*; D051379:Mice; D011247:Pregnancy; D047928:Premature Birth; D012189:Retrospective Studies; D012307:Risk Factors; D018746:Systemic Inflammatory Response Syndrome / Q000209:etiology